📣 Just out: onlinelibrary.wiley.com/doi/10.1002/... We show that oral–gut microbial translocation in advanced cirrhosis drives metabolic convergence and increased ammonia & acetate production, linking the microbiome to systemic metabolic stress. 🧠🔬 #Cirrhosis #Microbiome #Hepatology #LiverDisease
MICROB-PREDICT
@microb-predict.bsky.social
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 825694. #GutLiverAxis #microbiome #LiverSky #Hepatology #cirrhosis #ACLF Website: https://microb-predict.eu/
👏 Looking back: What a fantastic #EASLCongress 2026! 💪 50+ talks, posters, sessions & symposia, with outstanding work from early-career scientists. ✨ Main highlights: The MICROB-PREDICT Consensus Conference & Networking Session 🎉Congratulations to the whole team! #ACLF #microbiome #cirrhosis
New in @natgenet.nature.com: a moving obituary for Peer. Francesca Ciccarelli, Jan Korbel & Christian von Mering reflect on his scientific vision, from protein domains and genome evolution to metagenomics, and on his generosity as a mentor and friend to so many. www.nature.com/articles/s41...
Peer Bork (1963–2026) - Nature Genetics
Nature Genetics - Peer Bork (1963–2026)
nature.com
Our work exploring host-microbial co-metabolism of bile acids in patients with alcohol-related liver disease (ALD) has been published in the JHEP Reports: www.sciencedirect.com/science/arti... 🪐 A big thank you to everyone involved, to the GALAXY and MicrobLiver consortia who made this possible! 🙌
Alcohol-related liver disease disrupts bile acid homeostasis and gut microbial bile acid metabolism
Alcohol overuse disrupts liver function and alters gut microbial communities, with alcohol-related liver disease (ALD) causing half of all liver-relat…
sciencedirect.com
Why ELPA is going on a unique European Liver Screening Tour ELPA is going on a unique European Liver Screening Tour because Europe can no longer afford to wait for liver disease to become visible only when it is already advanced. For too long, liver disease has remained silent.
Back home from an inspiring & energising #EASLCongress in sunny + hot Barcelona 🌅. These were my personal highlights (sound on 🔊) - what were your‘s? 😎 #Barcelona #EASL2026 #LiverDisease #LiverHealth #ACLF @europeliver.bsky.social @medblab.bsky.social @horizoneu.bsky.social @easlnews.bsky.social
🩺 #POSTER SAT-532 by Markus Maagaard et al. evaluated if direct #prothrombin concentration🩸can improve prognostic performance of the #MELD (Model for End-Stage Liver Disease) score in patients with decompensated #cirrhosis (compared to INR, the international normalised ratio). @easlnews.bsky.social
😁 Those two had fun at their #Poster: Congratulations to Philipp Althaus & Sabine Klein together with other colleagues from the MedB Lab (Münster, Germany), on this excellent poster presentation at #EASLCongress 2026 this Saturday! @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social
👏 Two posters by David Tornai today at #EASLCongress! #POSTER SAT-414-YI explored the prognostic value of serum secretory #IgA in patients with #PSC. #POSTER SAT-415 evaluated circulating #macrophage activation markers as prognostic tools in #PSC. @easlnews.bsky.social @europeliver.bsky.social
🧬 Rocking the presentation of two posters at #EASLCongress 2026 - wow 🤩! 👏 Sania Arif did a great job at these posters today. #ACLF #Cirrhosis #Metabolomics #BacterialInfection #Hepatology #SystemicInflammation #Microbiome @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social
🩺 Mortality prediction using non-invasive fibrosis scores independent of chronic liver disease in patients with COVID-19: #POSTER SAT-515 by Maximilian Joseph Brol et al. 📍Presented at #EASLCongress #EASL2026 #COVID19 #LiverDisease #Fibrosis #Hepatology #ClinicalResearch @medblab.bsky.social
💪 Strong finish of #EASL2026 with ✨ Highlights from the MICROB-PREDICT Consensus Conference ✨ at our #Networking session - Thanks for coming 🤗! #Microbiome-based #mechanisms #biomarkers #PatientStratification #cirrhosis #ACLF @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social
💊 Non-selective #betablocker use was associated with improved survival across all stages of chronic #LiverDisease, including pre-ACLF & #ACLF: 👏 #POSTER SAT-458-YI by Josune Cabello Calleja et al. #EASL2026 #Cirrhosis #Hepatology @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social
Today at #EASLCongress 2026 🎤: Thesession "EASL / EF-CLIF: The Road Ahead – Horizon Scanning in #Cirrhosis & #PortalHypertension" spotlighted the next wave of evidence that could reshape the management of advanced #LiverDisease! @europeliver.bsky.social @easlnews.bsky.social @medblab.bsky.social
☺️ What a refreshingly honest #workshop on Friday eve: 💪 How can we turn setbacks into strengths? Former EASL Secretary General Aleksander Krag spoke with a group of #YoungInvestigators about his own career path that also included failures & setbacks. @easlnews.bsky.social #EASL2026 #EASLCongress
🧪 Minneke Coenraad (LUMC) chaired the last #PosterTour today on "Experimental and Pathophysiology" at the Cirrhosis & Complications Track Hub! 💫 Marie Bobowski-Gerard (GENFIT) did a fantastic job presenting this poster, a collaboration with @medblab.bsky.social: 👉 #Poster FRI-383 #EASLCongress
Congrats to V. Legry et al. on this #ACLF translational advance presented by Cristina López-Vicario at #EASLCongress, #POSTER FRI-412. ASK1 inhibitor SRT-015 reduced IL-6, IL-1β, TNFα & CXCL10 while preserving/enhancing antibacterial #ImmuneFunction, including phagocytosis & macrophage polarisation.
💬Prof. @aleksanderkrag.bsky.social co-chairs a symposium on #MetALD Key takeaways: • Structured diagnosis & prognosis • Managing AUD in liver patients • Integrating cardiometabolic risk control Focus: Practical application for #clinicalcare #Hepatology #EASL2026
👏 Minneke Coenraad's group (LUMC) has a strong presence during today's #PosterSession at #EASLCongress! See below what they investigated by watching our short movie clip 🎬... #Hepatology #LiverTransplantation #MELD #Cirrhosis @easlnews.bsky.social @europeliver.bsky.social @unileiden.bsky.social
✨ Poster Tour Highlight ✨ 🩺 Reductions in phosphatidylethanol #PEth are associated with improvements in #BloodPressure & lipid profile in steatotic liver disease #SLD. Shown by Nikolaj Torp et al. in #POSTER THU-204. #EASL2026 #SLD #MASLD #Hepatology @easlnews.bsky.social @europeliver.bsky.social
🦠 Incidence, risk factors & outcomes of #cytomegalovirus infection after liver transplantation: #POSTER FRI-474 by Maximilian Joseph Brol et al. investigates the incidence & clinical impact of CMV infection following #LiverTransplantation. 📍Presented at #EASLCongress #EASL2026 @medblab.bsky.social
We're back in the #EASLStudio. This time, @debbieshawcross.bsky.social, EASL Secretary General, chairs the session 'From evidence to action: Will the EASL-LANCET commission 2.0 move the needle on liver disease?' @thelancet.com @easlnews.bsky.social #EASL2026 #EASLCongress #liverdisease
🧬 Impaired endothelial FoxO1 signalling may contribute to endothelial dysfunction in ACLF. 👉 #POSTER FRI-428-YI by Fabian Schachteli et al. #EASL2026 #EASLCongress #ACLF #Cirrhosis #Hepatology @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social
🧬 Maladaptive emergency #myelopoiesis may drive progression from acutely decompensated cirrhosis to ACLF. 👉 #POSTER FRI-388-YI by Zhujun Cao et al. #EASLCongress #EASL2026 #ACLF #Cirrhosis #Immunology #DecompensatedCirrhosis @medblab.bsky.social @europeliver.bsky.social @easlnews.bsky.social
📊 A nationwide German study highlights changing trends in hepatocellular carcinoma severity, treatment strategies & complications 2005-2019: #POSTER FRI-220 by Josune Cabello Calleja et al. #EASL2026 #HCC #LiverCancer #Hepatology @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social
Prof. @aleksanderkrag.bsky.social (FLASH OUH) co-chairs today's #EASLStudio on the EASL-Lancet Commission on sustainable liver health in 🇪🇺 The session is dedicated to Michael Manns (1951-2025) @thelancet.com @easlnews.bsky.social #EASL2026
🛜 Conferences like #EASLCongress are the perfect chance to network, exchange ideas & collaborate ☺️: As part of the "German Cirrhosis Study Group", the MedB Lab is excited to be represented so strongly at #EASL2026 in Barcelona! #Hepatology #LiverResearch @medblab.bsky.social @easlnews.bsky.social
🌎 Regional variation in #Rifaximin use & #GutMicrobiota composition in European patients with decompensated #cirrhosis: ✨ The outstanding international collaboration & poster SAT-467-YI by Susan Fischer et al. was featured during today's afternoon #PosterTour at Track Hub 6! #EASL2026 #Hepatology
🧬Constitutive #MAS1 activation may reduce #LiverFibrosis and #PortalHypertension in chronic liver disease! 🚨See POSTER FRI-329 by Philipp Althaus et al. (last author + #PosterTour presenter today: Sabine Klein, @medblab.bsky.social at UKM) #EASLCongress #Hepatology #EASL2026 @easlnews.bsky.social
🚨 Michael Praktiknjo et al. validated a custom-built 22G #EUS-PPG system with great correlation to the commercial 25G platform. 👉 Lower cost💲+ better availability may expand access to #PortalHypertension assessment worldwide 🌎! @medblab.bsky.social @europeliver.bsky.social @easlnews.bsky.social